test

Justin Hirsch

@Octagon Capital Advisors Lp

Latest period2024 - Q3ReportedManaged Assets$642.902MTotal holdings41
Assets growth rate1.05%Assets growth rate (2-Q avg)-11.35%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Octagon Capital Advisors Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 41 positions.

Assets under management

The assets under management (AUM) of Octagon Capital Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 642.902M in assets, with a quarterly growth rate of 1.05% and a 2-quarter average growth rate of -11.35%. The portfolio is managed by Justin Hirsch, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
APLSApellis Pharmaceuticals Inc
Recent Activity
Decreased -6.93%
13.49%
$86.721M
3.007M shares@ $28.84 avg price
VRNAVerona Pharma Plc
Recent Activity
Decreased -3.16%
8.22%
$52.799M
1.835M shares@ $28.77 avg price
GPCRStructure Therapeutics Inc
Recent Activity
Increased 5.09%
8.18%
$52.58M
1.198M shares@ $43.89 avg price
INSMInsmed Inc
Recent Activity
Decreased -23.7%
7.8%
$50.138M↑ Call
686,820 shares@ $73.0 avg price
DNTHDianthus Therapeutics Inc
Recent Activity
7.44%
$47.824M
1.747M shares@ $27.38 avg price
AVBPArrivent Biopharma Inc
Recent Activity
Increased 9.6%
7.23%
$46.445M
1.976M shares@ $23.51 avg price
CNTACentessa Pharmaceuticals Plc
Recent Activity
Decreased -14.2%
5.01%
$32.173M
2.012M shares@ $15.99 avg price
NUVBNuvation Bio Inc
Recent Activity
Increased 2720.1%
4.34%
$27.873M
12.172M shares@ $2.3 avg price
CRBPCorbus Pharmaceuticals Hldgs
Recent Activity
Increased 128.49%
3.58%
$23.002M
1.115M shares@ $20.63 avg price
OCULOcular Therapeutix Inc
Recent Activity
3.29%
$21.098M
2.425M shares@ $8.7 avg price